Lucid Diagnostics Inc. (LUCD) vs Quanterix Corporation (QTRX)

Lucid Diagnostics Inc. and Quanterix Corporation are both Medical Devices companies. Lucid Diagnostics Inc. is the larger, with a market value of $170.3M against $150.4M — 1.1× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against 22.0%. Quanterix Corporation has the higher net margin (−80.3% vs −1,193.9%) and the higher return on invested capital (−66.5% vs −3,096.5%). Across the 17 metrics below, Quanterix Corporation leads on 11 and Lucid Diagnostics Inc. on 6.

Valuation

Metric LUCD QTRX Medical Devices median
P/E n/m n/m 22.18
P/S 27.91 1.01 2.70
P/B 13.91 0.65 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 26.10 0.43 2.38
Earnings yield (56.63%) (80.43%) (8.22%)
Free cash flow yield (31.04%) (52.96%) (7.80%)

Profitability

Metric LUCD QTRX Medical Devices median
Gross margin (21.69%) 44.56% 56.01%
Operating margin (930.84%) (99.65%) (15.03%)
Net margin (1,193.87%) (80.25%) (20.40%)
Free cash flow margin (866.56%) (53.24%) (7.24%)
Return on equity 364.89% (46.48%) (15.32%)
Return on assets (167.51%) (35.41%) (19.72%)
Return on invested capital (3,096.53%) (66.50%) (10.33%)

Growth

Metric LUCD QTRX Medical Devices median
Revenue growth (TTM) 24.89% 21.96% 8.80%
EPS growth (last fiscal year) 34.29% (151.00%) —
Revenue growth, 5-year CAGR — 9.97% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LUCD QTRX Medical Devices median
Debt to equity 2.15 0.00 0.07
Current ratio 1.33 3.40 2.50
Net debt to EBITDA 0.22 1.16 0.49

Dividend

Metric LUCD QTRX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric LUCD QTRX Medical Devices median
Market cap 170.32m 150.39m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack